FZD7

Chr 2

frizzled class receptor 7

Also known as: FzE3

The FZD7 protein is a seven-transmembrane receptor for Wnt signaling proteins that activates the canonical beta-catenin pathway and non-canonical Wnt responses involved in cell polarity and tissue morphogenesis. Mutations cause autosomal recessive retinal dystrophy, with patients developing progressive vision loss typically beginning in childhood. FZD7 is moderately constrained against loss-of-function variants, reflecting its important role in retinal development and maintenance.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 0.61
Clinical SummaryFZD7
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.29) despite low pLI — interpret in context.
📋
ClinVar Variants
31 unique Pathogenic / Likely Pathogenic· 63 VUS of 97 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.61LOEUF
pLI 0.088
Z-score 2.75
OE 0.29 (0.150.61)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
2.03Z-score
OE missense 0.70 (0.630.78)
257 obs / 366.5 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios
LoF OE0.29 (0.150.61)
00.351.4
Missense OE0.70 (0.630.78)
00.61.4
Synonymous OE1.21
01.21.6
LoF obs/exp: 5 / 17.4Missense obs/exp: 257 / 366.5Syn Z: -2.14
DN
0.7229th %ile
GOF
0.78top 25%
LOF
0.2484th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

97 submitted variants in ClinVar

Classification Summary

Pathogenic30
Likely Pathogenic1
VUS63
Likely Benign1
Benign2
30
Pathogenic
1
Likely Pathogenic
63
VUS
1
Likely Benign
2
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
30
0
30
Likely Pathogenic
0
0
1
0
1
VUS
0
60
3
0
63
Likely Benign
0
0
0
1
1
Benign
0
1
0
1
2
Total06134297

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

FZD7 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →